The C-Terminal Domain of the Arabinosyltransferase EmbC Is a Lectin-Like Carbohydrate Binding Module
The d-arabinan-containing polymers arabinogalactan (AG) and lipoarabinomannan (LAM) are essential components of the unique cell envelope of the pathogen Mycobacterium tuberculosis. Biosynthesis of AG and LAM involves a series of membrane-embedded arabinofuranosyl (Araf) transferases whose structures are largely uncharacterised, despite the fact that several of them are pharmacological targets of ethambutol, a frontline drug in tuberculosis therapy. Herein, we present the crystal structure of the C-terminal hydrophilic domain of the ethambutol-sensitive Araf transferase M. tuberculosis EmbC, which is essential for LAM synthesis. The structure of the C-terminal domain of EmbC (EmbCCT) encompasses two sub-domains of different folds, of which subdomain II shows distinct similarity to lectin-like carbohydrate-binding modules (CBM). Co-crystallisation with a cell wall-derived di-arabinoside acceptor analogue and structural comparison with ligand-bound CBMs suggest that EmbCCT contains two separate carbohydrate binding sites, associated with subdomains I and II, respectively. Single-residue substitution of conserved tryptophan residues (Trp868, Trp985) at these respective sites inhibited EmbC-catalysed extension of LAM. The same substitutions differentially abrogated binding of di- and penta-arabinofuranoside acceptor analogues to EmbCCT, linking the loss of activity to compromised acceptor substrate binding, indicating the presence of two separate carbohydrate binding sites, and demonstrating that subdomain II indeed functions as a carbohydrate-binding module. This work provides the first step towards unravelling the structure and function of a GT-C-type glycosyltransferase that is essential in M. tuberculosis.
Vyšlo v časopise:
The C-Terminal Domain of the Arabinosyltransferase EmbC Is a Lectin-Like Carbohydrate Binding Module. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001299
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001299
Souhrn
The d-arabinan-containing polymers arabinogalactan (AG) and lipoarabinomannan (LAM) are essential components of the unique cell envelope of the pathogen Mycobacterium tuberculosis. Biosynthesis of AG and LAM involves a series of membrane-embedded arabinofuranosyl (Araf) transferases whose structures are largely uncharacterised, despite the fact that several of them are pharmacological targets of ethambutol, a frontline drug in tuberculosis therapy. Herein, we present the crystal structure of the C-terminal hydrophilic domain of the ethambutol-sensitive Araf transferase M. tuberculosis EmbC, which is essential for LAM synthesis. The structure of the C-terminal domain of EmbC (EmbCCT) encompasses two sub-domains of different folds, of which subdomain II shows distinct similarity to lectin-like carbohydrate-binding modules (CBM). Co-crystallisation with a cell wall-derived di-arabinoside acceptor analogue and structural comparison with ligand-bound CBMs suggest that EmbCCT contains two separate carbohydrate binding sites, associated with subdomains I and II, respectively. Single-residue substitution of conserved tryptophan residues (Trp868, Trp985) at these respective sites inhibited EmbC-catalysed extension of LAM. The same substitutions differentially abrogated binding of di- and penta-arabinofuranoside acceptor analogues to EmbCCT, linking the loss of activity to compromised acceptor substrate binding, indicating the presence of two separate carbohydrate binding sites, and demonstrating that subdomain II indeed functions as a carbohydrate-binding module. This work provides the first step towards unravelling the structure and function of a GT-C-type glycosyltransferase that is essential in M. tuberculosis.
Zdroje
1. World Health Organisation 2009 Global Tuberculosis Control: a short update to the 2009 report (http://www.who.int/entity/tb/publications/2009/factsheet_tb_2009update_dec09.pdf)
2. HarriesAD
DyeC
2006 Tuberculosis. Ann Trop Med Parasitol 100 415 431
3. JainA
MondalR
2008 Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol Med Microbiol 53 145 150
4. CrickDC
MahapatraS
BrennanPJ
2001 Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis. Glycobiology 11 107R 118R
5. BrikenV
PorcelliSA
BesraGS
KremerL
2004 Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 53 391 403
6. BelangerAE
BesraGS
FordME
MikusovaK
BelisleJT
1996 The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci U S A 93 11919 11924
7. TelentiA
PhilippWJ
SreevatsanS
BernasconiC
StockbauerKE
1997 The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3 567 570
8. EscuyerVE
LetyMA
TorrellesJB
KhooKH
TangJB
2001 The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. J Biol Chem 276 48854 48862
9. ZhangN
TorrellesJB
McNeilMR
EscuyerVE
KhooKH
2003 The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. Mol Microbiol 50 69 76
10. BergS
StarbuckJ
TorrellesJB
VissaVD
CrickDC
2005 Roles of conserved proline and glycosyltransferase motifs of EmbC in biosynthesis of lipoarabinomannan. J Biol Chem 280 5651 5663
11. ShiL
BergS
LeeA
SpencerJS
ZhangJ
2006 The carboxy terminus of EmbC from Mycobacterium smegmatis mediates chain length extension of the Arabinan in lipoarabinomannan. J Biol Chem 281 19512 19526
12. AlderwickLJ
SeidelM
SahmH
BesraGS
EggelingL
2006 Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis. J Biol Chem 281 15653 15661
13. SeidelM
AlderwickLJ
BirchHL
SahmH
EggelingL
2007 Identification of a novel arabinofuranosyltransferase AftB involved in a terminal step of cell wall arabinan biosynthesis in Corynebacterianeae, such as Corynebacterium glutamicum and Mycobacterium tuberculosis. J Biol Chem 282 14729 14740
14. SeidelM
AlderwickLJ
SahmH
BesraGS
EggelingL
2007 Topology and mutational analysis of the single Emb arabinofuranosyltransferase of Corynebacterium glutamicum as a model of Emb proteins of Mycobacterium tuberculosis. Glycobiology 17 210 219
15. LiuJ
MushegianA
2003 Three monophyletic superfamilies account for the majority of the known glycosyltransferases. Protein Sci 12 1418 1431
16. LeeRE
MikusovaK
BrennanPJ
BesraGS
1995 Synthesis of the mycobacterial arabinose donor beta-D-arabinofuranosyl-1-monophosphoryldecaprenol, development of a basic arabinosyl-transferase assay, and identification of ethambutol as an arabinosyl transferase inhibitor. J Am Chem Soc 117 11829 11832
17. WoluckaBA
McNeilMR
de HoffmannE
ChojnackiT
BrennanPJ
1994 Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J Biol Chem 269 23328 23335
18. AminAG
GoudeR
ShiL
ZhangJ
ChatterjeeD
2008 EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis. Microbiology 154 240 248
19. GoudeR
AminAG
ChatterjeeD
ParishT
2008 The critical role of embC in Mycobacterium tuberculosis. J Bacteriol 190 4335 4341
20. RamaswamySV
AminAG
GokselS
StagerCE
DouSJ
2000 Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 44 326 336
21. BorastonAB
BolamDN
GilbertHJ
DaviesGJ
2004 Carbohydrate-binding modules: fine-tuning polysaccharide recognition. Biochem J 382 769 781
22. HardingMM
2001 Geometry of metal-ligand interactions in proteins. Acta Crystallogr D Biol Crystallogr 57 401 411
23. HolmL
SanderC
1996 Mapping the protein universe. Science 273 595 603
24. IguraM
MaitaN
KamishikiryoJ
YamadaM
ObitaT
2008 Structure-guided identification of a new catalytic motif of oligosaccharyltransferase. EMBO J 27 234 243
25. LeeRE
BrennanPJ
BesraGS
1997 Mycobacterial arabinan biosynthesis: the use of synthetic arabinoside acceptors in the development of an arabinosyl transfer assay. Glycobiology 7 1121 1128
26. PiresVM
HenshawJL
PratesJA
BolamDN
FerreiraLM
2004 The crystal structure of the family 6 carbohydrate binding module from Cellvibrio mixtus endoglucanase 5a in complex with oligosaccharides reveals two distinct binding sites with different ligand specificities. J Biol Chem 279 21560 21568
27. BardarovS
BardarovSJJr
PavelkaMSJJr
SambandamurthyV
LarsenM
2002 Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148 3007 3017
28. BhamidiS
SchermanMS
McNeilMR
2009 Mycobacterial cell wall arabinogalactan: a detailed perspective on structure, biosynthesis, functions and drug tageting.
UllrichM
Bacterial polysaccharides Norfolk, UK Caister Academic Press 39 65
29. WalserPJ
HaebelPW
KunzlerM
SargentD
KuesU
2004 Structure and functional analysis of the fungal galectin CGL2. Structure 12 689 702
30. Van DuyneGD
StandaertRF
KarplusPA
SchreiberSL
ClardyJ
1993 Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J Mol Biol 229 105 124
31. KabschW
1993 Automatic processing of rotation diffraction data from crystals of initially unknown cell constants and symmetry. J Appl Crystallogr 26 795 800
32. SheldrickGM
2008 A short history of SHELX. Acta Crystallogr A 64 112 122
33. de la FortelleE
BricogneG
1997 Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multi-wavelength anomalous diffraction methods. Methods Enzymol 276 472 494
34. AbrahamsJP
LeslieAG
1996 Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr D Biol Crystallogr 52 30 42
35. MorrisRJ
PerrakisA
LamzinVS
2002 ARP/wARP's model-building algorithms. I. The main chain. Acta Crystallogr D Biol Crystallogr 58 968 975
36. EmsleyP
CowtanK
2004 Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60 2126 2132
37. MurshudovGN
VaginAA
DodsonEJ
1997 Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53 240 255
38. AdamsPD
Grosse-KunstleveRW
HungLW
IoergerTR
McCoyAJ
2002 PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58 1948 1954
39. WinnMD
IsupovMN
MurshudovGN
2001 Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr 57 122 133
40. SchuckP
2000 Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J 78 1606 1619
41. StoverCK
de la CruzVF
FuerstTR
BurleinJE
BensonLA
1991 New use of BCG for recombinant vaccines. Nature 351 456 460
42. NigouJ
GilleronM
CahuzacB
BouneryJD
HeroldM
1997 The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guerin. Heterogeneity, structure, and role in the regulation of cytokine secretion. J Biol Chem 272 23094 23103
43. GouetP
CourcelleE
StuartDI
MetozF
1999 ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15 305 308
44. Jamal-TalabaniS
BorastonAB
TurkenburgJP
TarbouriechN
DucrosVM
2004 Ab initio structure determination and functional characterization of CBM36; a new family of calcium-dependent carbohydrate binding modules. Structure 12 1177 1187
45. van BuerenAL
MorlandC
GilbertHJ
BorastonAB
2005 Family 6 carbohydrate binding modules recognize the non-reducing end of beta-1,3-linked glucans by presenting a unique ligand binding surface. J Biol Chem 280 530 537
46. HenshawJ
Horne-BitschyA
van BuerenAL
MoneyVA
BolamDN
2006 Family 6 carbohydrate binding modules in beta-agarases display exquisite selectivity for the non-reducing termini of agarose chains. J Biol Chem 281 17099 17107
47. DavisIW
Leaver-FayA
ChenVB
BlockJN
KapralGJ
2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35 W375 83
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 2
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Genetic Mapping Identifies Novel Highly Protective Antigens for an Apicomplexan Parasite
- Type I Interferon Signaling Regulates Ly6C Monocytes and Neutrophils during Acute Viral Pneumonia in Mice
- Infections in Cells: Transcriptomic Characterization of a Novel Host-Symbiont Interaction
- The ESCRT-0 Component HRS is Required for HIV-1 Vpu-Mediated BST-2/Tetherin Down-Regulation